本文已被:浏览 86次 下载 38次
投稿时间:2023-10-08
投稿时间:2023-10-08
中文摘要: 探究富硒绿茶提取物对肠道菌群失调小鼠的影响,采用头孢曲松钠进行肠道菌群失调模型的建立,检测小鼠肠组织中分泌型免疫球蛋白A(secretory immunoglobulin A, SIgA)、脂多糖(lipopolysaccharide, LPS)和小鼠粪便中短链脂肪酸(short-chain fatty acids,SCFAs)含量,并通过16S rRNA 高通量测序检测富硒绿茶提取物对小鼠肠道菌群的调节作用。结果表明,富硒绿茶提取物显著提高肠道菌群失调小鼠回肠SIgA 含量、小鼠粪便中SCFAs 含量,降低小鼠结肠组织中LPS 含量,相比普通绿茶,富硒绿茶具有更强的肠道免疫调节和抗炎优势。高通量测序结果显示,富硒绿茶提取物可以显著调节头孢曲松钠引起的小鼠肠道微生物多样性改变,抑制变形菌和放线菌的生长和促进毛螺旋菌、阿克曼菌、拟杆菌等有益菌的繁殖,因此富硒绿茶提取物具有调节小鼠肠道菌群的作用。
中文关键词: 富硒绿茶 肠道菌群 16S rRNA 高通量测序 硒 头孢曲松钠
Abstract:To explore the effects of selenium-enriched green tea extract on mice with intestinal flora dysregulation, ceftriaxone sodium was used to establish the intestinal flora dysregulation model. Changes in the levels of secretory immunoglobulin A(SIgA) and lipopolysaccharide(LPS) in the intestinal tissues, as well as shortchain fatty acids (SCFAs) in mouse feces, were detected. The regulatory effect of selenium-enriched green tea extract on intestinal flora in mice was detected using 16S rRNA high-throughput sequencing. The results showed that selenium-enriched green tea extract significantly increased the SIgA content in the ileum of intestinal flora-dysregulated mice, enhanced SCFAs content in feces, and decreased the LPS content in colon tissue.Compared to ordinary green tea, selenium-enriched green tea extract exhibited stronger intestinal immunomodulatory and anti-inflammatory effects. High-throughput sequencing results showed that selenium-enriched green tea extract could significantly regulate the changes in intestinal microbial diversity induced by ceftriaxone sodium in mice. It inhibited the growth of Proteobacteria and Actinomyces while promoting the proliferation of beneficial bacteria such as Lachnospiraceae, Akkermansia, and Bacteroides. Therefore, selenium-enriched green tea extract could effectively regulate the intestinal microflora of mice.
keywords: selenium-enriched green tea intestinal floras 16S rRNA high-throughput sequencing selenium ceftriaxone
文章编号:202507002 中图分类号: 文献标志码:
基金项目:国家自然科学基金项目(21966011);中央引导地方科技发展资金项目(2022ZY0049);贵州省科技计划项目(黔科中引地[2021]4039)
作者 | 单位 |
陶会1,徐婵1,宋杰玉1,李进1,滕春丽2,潘灿平3,杨鸿波1,2 *,魏绍峰1 | 1.贵州医科大学 公共卫生与健康学院,贵州 贵阳 550025;2.贵州健安德科技有限公司,贵州 贵阳 550014;3.中国农业大学 理学院,北京 100094 |
引用文本: